Vincent Mark D. 4
4 · Aptose Biosciences Inc. · Filed Jan 20, 2022
Insider Transaction Report
Form 4
Vincent Mark D.
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2022-01-18+50,000→ 50,000 totalExercise: $1.39Exp: 2032-01-17→ Common Shares (50,000 underlying)
Footnotes (2)
- [F1]Converted from Canadian exercise price of C$1.74 using an exchange rate of C$1.2529 = US$1.00.
- [F2]The options were granted on January 18, 2022, and vest as follows: 50% vest on January 18, 2023; 25% vest on January 18, 2024; and 25% vest on January 18, 2025.